Ten common questions (and their answers) about off-label drug use

Wittich, Christopher M., Burkle, Christopher M., Lanier, William L.·2012·Mayo Clinic Proceedings
DOI 10.1016/j.mayocp.2012.04.017

Cited by (366)

Items 101–200 of 366

  1. Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-2016
    Laila Tanana, Christopher M Harrison, Prasad S. Nishtala, Timothy Frank Chen · 2022 · European Neuropsychopharmacology
  2. A nationwide evaluation of off-label drug utilization in Turkey
    Emine Nur Özdamar, Ahmet Akıcı, Ali Alkan, Banu Bayar, Hakkı Gürsöz · 2017 · TURKISH JOURNAL OF MEDICAL SCIENCES
  3. Off-label prescriptions in intensive care unit: the Chinese experience
    Lin Liu, Hongyu Yang, Yan Lou, Jing Miao, Xiaoyang Lu, Qingwei Zhao, Rongrong Wang, Saiping Jiang, Xingguo Zhang · 2018 · Therapeutics and Clinical Risk Management
  4. Mathematics and Statistics
    Bronwyn H. Hall, Christian Helmers · 2024 · Oxford University Press eBooks
  5. Off-label innovation: characterization through a case study of rhBMP-2 for spinal fusion
    Zane Schnurman, Michael L. Smith, Douglas S Kondziolka · 2016 · Journal of Neurosurgery Spine
  6. Off-label use of drugs in regional anesthesia: A need for setting up policies
    Saru Singh, Pranav Bansal, Jagdish Dureja · 2017 · Journal of Anaesthesiology Clinical Pharmacology
  7. COVID ‐19 and the generation of novel scientific knowledge: Research questions and study designs
    Lucie O. M. Perillat, Brian S. Baigrie · 2021 · Journal of Evaluation in Clinical Practice
  8. Legal geographies of medication abortion in the USA
    Sydney Calkin · 2021 · Transactions of the Institute of British Geographers
  9. Drug Repurposing
    Alan Talevi · 2021 · Elsevier eBooks
  10. Staying on track when prescribing off-label.
    April S. Fitzgerald, Patrick G. O’Malley · 2014 · PubMed
  11. Stem cell therapy as a promising approach for ischemic stroke treatment
    Sahar Yaqubi, Mohammad Karimian · 2024 · Current Research in Pharmacology and Drug Discovery
  12. Off-Label Drug Use in Pediatric Practice: Unsolved Problems
    A. R. Titova, Irina L. Asetskaya, Sergey Kensarinovich Zyryanov, В. А. Поливанов · 2015 · Педиатрическая фармакология
  13. Racial-Ethnic Differences in Off-Label Antidepressant Use, by Insurance Type
    Dooyoung Lim, Jeah Kyoungrae Jung · 2017 · Psychiatric Services
  14. Clinical application of genomic high-throughput data: Infrastructural, ethical, legal and psychosocial aspects
    Nadine Umbach, Tim Beißbarth, Annalen Bleckmann, Gunnar Duttge, Laura Flatau, Alexander Otto König, Jessica Kuhn, Júlia Perera‐Bel, Julia Roschauer, Thomas G. Schulze et al. · 2019 · European Neuropsychopharmacology
  15. Assessing and Restoring Patency in Midline Catheters
    Michelle L. Hawes · 2020 · Journal of Infusion Nursing
  16. Starting a pediatric contrast ultrasound service: made simple!
    Kassa Darge, Susan J. Back, Richard A. Barth, Ann M. Johnson, Jeannie K. Kwon, M. Beth McCarville, Trudy A. Morgan, Aikaterini Ntoulia, Laura Poznick, Sphoorti Shellikeri et al. · 2021 · Pediatric Radiology
  17. Pimping up Drugs Recovered, Superannuated and Under Exploited Drugs - An Introduction to the Basics of Drug Reprofiling
    Suzanne J. Dilly, George S. Morris · 2017 · Current Drug Discovery Technologies
  18. Off-label prescription of drugs at hospital.
    Vicente Arocas Casañ, J Mateo Carmona, Olga García Molina, M. Espinosa, Ma José Blázquez Álvarez, Ma Amelia de la Rubia Nieto, Jesús del Río García · 2016 · PubMed
  19. Drug Research
    Sushmita Srivastava; Md. Faheem Haider; Afroz Ahmad; Usama Ahmad; Muhammad Arif; Asad Ali · 2026 · Drug Research
  20. Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study
    Sadia Shakeel, Shagufta Nesar, Hina Rehman, Khizra Jamil, Imran Ahsan Mallick, Muhammad Shahid Mustafa, Mudassir Anwar, Shazia Qasim Jamshed · 2021 · Pharmacy
  21. Investigation of Psychoactive Medications: Challenges and a Practical and Scalable New Path
    Dekel Taliaz, Alessandro Serretti · 2022 · CNS & Neurological Disorders - Drug Targets
  22. Remifentanil patient-controlled analgesia for labour: learning points from a registry
    Andrea Anna Melber, Thierry Girard, Moira Baeriswyl, P. Knessl, Georges Louis Savoldelli · 2016 · International Journal of Obstetric Anesthesia
  23. Role of botulinum neurotoxin–A in cerebral revascularization graft vasospasm prevention: current state of knowledge
    Kristīne Rāviņa, Ben Allen Strickland, Robert Charles Rennert, Joseph Nicholas Carey, Jonathan Joseph Russin · 2019 · Neurosurgical FOCUS
  24. Pharmacoepidemiology of medications omitted in New Zealand Residential Aged Care Homes
    Stephanie Garratt, Ngaire M Kerse, Kathryn Peri, Monique Jonas, Shane Lindsay Scahill · 2020 · Australian Journal on Ageing
  25. Responsabilidade médica e prescrição off-label de medicamentos no tratamento da COVID-19
    Flaviana Rampazzo Soares, Luciana Dadalto · 2020 · Revista IBERC
  26. An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression
    Laila Tanana, Asam Latif, Prasad S. Nishtala, David M. Taylor, Timothy Frank Chen · 2021 · Journal of Child and Adolescent Psychopharmacology
  27. Off-label Drug Prescription Pattern and Related Adverse Drug Reactions in the Medical Intensive Care Unit
    Jignesh Navinchandra Shah, Asawari Raut, Kavita K Krishna, Utkarsha Adake, Apurva A Sharma, Anitta Thomas · 2021 · Indian Journal of Critical Care Medicine
  28. Choosing Wisely
    Douglas Urness, Naomi J. Parker, Mark Jeffrey Rapoport, Thomas Christopher Wilkes · 2016 · The Canadian Journal of Psychiatry
  29. Off-Label Drugs in Neonatology: Analyses Using Large Data Bases
    Alan Hall Jobe · 2019 · The Journal of Pediatrics
  30. Entrepreneurship in Off-Label Drug Prescription: Just What the Doctor Ordered!
    Raymond J. March · 2015 · SSRN Electronic Journal
  31. Off-label Prescription in Paediatric Dermatology: A Retrospective Observational Study in a Tertiary Hospital
    Carmen Couselo‐Rodríguez, Ana Batalla, Sandra Martínez‐Fernández, Carmela Dávila-Pousa, Diego Soto‐García, Lucía Vilanova‐Trillo, Ángeles Flórez · 2023 · Acta Dermato Venereologica
  32. Regulatory Challenges to Emergency Medicine Procedural Sedation
    Steven M. Green, Ashley Booth Norse, Benjamin F. Jackson, Margaret Jean Carman, Mark G. Roback · 2020 · Annals of Emergency Medicine
  33. Barriers and facilitators to guideline for the management of pediatric off-label use of drugs in China: a qualitative descriptive study
    Min Meng, Jiale Hu, Xiao Liu, Min Tian, Wenjuan Lei, Enmei Liu, Zhu Han, Qiu Li, Yaolong Chen · 2024 · BMC Health Services Research
  34. Approaches of pre-clinical and clinical trials of repurposed drug
    Juveriya Israr, Shabroz Alam, Ajay Kumar · 2024 · Progress in molecular biology and translational science
  35. Pathways for non-manufacturers to drive generic drug repurposing for cancer in the U.S.
    Devon Crittenden, Raquel Gallagher, Fernanda Milans del Bosch, David M. Fox, Laura B. Kleiman · 2024 · Frontiers in Pharmacology
  36. Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative study
    Melanie C. Chansky, Simani M. Price, Kathryn J. Aikin, Amie C. O’Donoghue · 2022 · BMC Family Practice
  37. Gambaran Penggunaan Obat Off-Label Pada Pasien Pediatrik Rawat Inap di Rumah Sakit
    Teti Sutriati Tuloli, Nur Rasdianah, Andi Makkulawu, Dizky Ramadani Putri Papeo, Maimun Datau · 2022 · Indonesian Journal of Pharmaceutical Education
  38. Judicial and legislative practice and related suggestions on off-label drug use in China
    Wenjie Si, Panpan Ma · 2023 · BMC Health Services Research
  39. The Economics of Innovation and Intellectual Property
    Bronwyn H. Hall, Christian Helmers · 2024
  40. Physician-pharmacist agreement about off-label use of medications in private clinical settings in Baghdad, Iraq
    Saad A. Hussain, Ashwaq Najemaldeen Abbas, Hasan A Alhadad, Ali Azeez Al‐Jumaili, Zainab Saad Abdulrahman · 2017 · Pharmacy Practice
  41. On ciprofloxacin concentration in chronic rhinosinusitis
    José Gameiro dos Santos, Rosário Figueirinhas, José P. Liberal, João Carvalho Almeida, Joana Sousa, Amílcar C. Falcão, Corália Maria Fortuna de Brito Vicente, João C. Paço, Cecília Almeida e Sousa · 2017 · Acta Otorrinolaringológica Española
  42. Determining Associations with Word Embedding in Heterogeneous Network for Detecting Off-Label Drug Uses
    Christopher C. Yang, Mengnan Zhao · 2017 · IEEE International Conference on Healthcare Informatics (ICHI)
  43. The significance of the US Food and Drug Administration for dental professionals and safe patient care
    Fiona M. Collins · 2017 · The Journal of the American Dental Association
  44. Dispensing Medical Countermeasures: Emergency Use Authorities and Liability Protections
    Charles G. Kels · 2015 · Health Security
  45. Drug Information Training for Pharmacists
    Dixon Thomas, Ivellise Costa de Sousa, David John Woods, Ronald A. Herman, Danial E. Baker · 2019 · Elsevier eBooks
  46. Antiviral Therapy during the Coronavirus Disease (COVID-19) Pandemic: Is It Appropriate to Treat Patients in the Absence of Significant Evidence?
    Bruce Dalton, Linda Dresser, Daniel J. G. Thirion, Tim T Y Lau · 2020 · The Canadian Journal of Hospital Pharmacy
  47. Off-label drug use in pediatric wards: a prospective study in a tertiary care hospital in Pune
    Faizal Vohra, Sunita Pawar · 2016 · Egyptian Pharmaceutical Journal
  48. Off-label, but on-target: Use of regadenoson with exercise
    Robert C. Hendel, Lauren E. Frost · 2012 · Journal of Nuclear Cardiology
  49. Annotating off-label drug usage from unconventional sources
    Avram, Sorin, Halip, Liliana, Curpan, Ramona, Borota, Ana, Bora, Alina, Oprea, Tudor I · 2022 · medRxiv
  50. Impact of the EMA/FDA alerts on the use of effective contraceptive method in women of childbearing age undergoing valproic acid treatment in a long-stay psychiatric center
    María Puig-Moltó, Emilio Pol Yanguas, Lidia Segarra, Blanca Lumbreras · 2020 · Epilepsy & Behavior
  51. Off-label drug use and the risk of medication errors in critically ill neonates: A conceptual pilot study
    Kannan Sridharan, Muna Al Jufairi, Eman Al Ansari · 2021 · International Journal of Risk & Safety in Medicine
  52. On the issue of efficacy and safety of prescription of pharmacological agents in pediatric practice
    Л. А. Харитонова, Konstantin I. Grigoriev · 2022 · Экспериментальная и клиническая гастроэнтерология
  53. Converting a drug from off‐label to on‐label use: Government subsidies and patient welfare
    Wendy Olsder, Tugce Martagan, Christopher S. Tang · 2022 · Decision Sciences
  54. Rectal use of levetiracetam: best practice report for a stepwise approach for sustainable off-label decision making and treatment
    Constanze Rémi, Alina Hermann, Elisabeth Krull, Franziska Ockert-Schön, Jan Rémi · 2023 · International Journal of Clinical Pharmacy
  55. General Principles of Psychopharmacology
    James M. Williams, George Thomas Grossberg · 2018 · Springer eBooks
  56. Clinical Trials of Repurposing Medicines in Acute Myeloid Leukemia
    Vibeke Andresen, Bjørn Tore Gjertsen · 2019 · The Cancer Journal
  57. Off‐Label Prescribing by Psychiatrists: What is the Practitioner's Liability?
    Christophe Bartoli, Caroline Berland-Benhaïm, Caroline Sastre, Valérie Baillif‐Couniou, Pascal Kintz, Georges Léonetti, Anne‐Laure Pélissier‐Alicot · 2015 · Journal of Forensic Sciences
  58. Off-Label Medicines Use: Complex Problem of Modern Clinical Practice
    S. R. Gilyarevskiy · 2020 · Rational Pharmacotherapy in Cardiology
  59. Takotsubo Cardiomyopathy Due to Combined Use of Phentermine and Lisdexamfetamine
    Tara Burleigh, Khandalavala Birgit · 2020 · European Journal of Case Reports in Internal Medicine
  60. Off-Label Drug Use: The Bevacizumab Story
    Michael W. Stewart · 2013 · Mayo Clinic Proceedings
  61. Pharmacogenetic Associations and Evidence-Based Pharmacogenomics Guidelines: Supporting Label and Off-Label Use of Drug–Gene Interaction Data
    David F. Kisor, Andrew A. Monte, Daniel J. Müller · 2020 · Pharmacogenomics
  62. From Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education
    Ronaldo Morales, Victor Amajor, Kelli M. Paice, Kathryn E. Kyler, Horace Rhodes Hambrick, Kathryn E. Pavia, Andrew S. Haynes, Felicia Gooden, Gwendolyn M. Pais, Kevin J. Downes et al. · 2024 · Clinical Pharmacology & Therapeutics
  63. Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs
    Andrew Ivsins, Jeanette M. Bowles, Manal Mansoor, Thomas H Kerr, Geoff Bardwell · 2024 · International Journal of Drug Policy
  64. Contrast Media in Children: Ten Important Concepts on Administration, Applications, Complications, and Environmental Considerations, From the AJR Special Series on Contrast Media
    Monica M. Forbes-Amrhein, Jeanne S. Chow, Kelly K. Horst, Helen H. R. Kim, Rajesh Krishnamurthy, Ezekiel J. Maloney, R.J. McDonald, Leah A. Gilligan, Deborah R. Stein, Michael J. Callahan · 2024 · American Journal of Roentgenology
  65. Off-label use of medicines in South Africa: a review
    Nokwanda Nhlanzeko Ngcobo, Lehlohonolo John Mathibe · 2024 · Orphanet Journal of Rare Diseases
  66. Adjuncts for neuraxial anaesthesia in obstetrics
    Ralph Kempenaers, Eva Roofthooft, Marc Van de Velde · 2025 · BJA Education
  67. What are the ethical and legal considerations when your patient refuses the standard of care?
    Tara L. Braun, Viraat Patel, Harry Dao, Theodore Rosen · 2019 · Dermatology Online Journal
  68. Drug repurposing for neurodegenerative diseases
    Halak Shukla, Diana John, Shuvomoy Banerjee, Anand Krishna Tiwari · 2024 · Progress in molecular biology and translational science
  69. Obat Off-Label Pada Anak di Pelayanan Rawat Jalan Klinik Pratama Swasta Kabupaten Sleman Yogyakarta
    Ndaru Setyaningrum, Haudatul Khamsani, Rosita Mulyawati · 2019 · Jurnal Sains Farmasi & Klinis
  70. The changing landscape of off-label prescription drug promotion
    Matthew E. Sarkees, M. Paula Fitzgerald · 2016 · International Journal of Pharmaceutical and Healthcare Marketing
  71. Automated Off-label Drug Use Detection from User Generated Content
    Mengnan Zhao, Christopher C. Yang · 2017 · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB)
  72. Off-Label Drug Use Detection Based on Heterogeneous Network Mining
    Mengnan Zhao · 2017 · IEEE International Conference on Healthcare Informatics (ICHI)
  73. Knowledge and attitudes of patients in primary care on off-label treatment
    Mario Ćurković, Dražen Gorjanski · 2018 · International Journal of Risk & Safety in Medicine
  74. Polypharmacy and Off-label Drug Use in Dentistry: knowledge, attitudes and practices of California dental hygienists.
    Kristen M Stephens, Tara Lynn Johnson, JoAnn R Gurenlian · 2018 · PubMed
  75. Exploiting OHC Data with Tensor Decomposition for Off-Label Drug Use Detection
    Mengnan Zhao, Christopher C. Yang · 2018 · IEEE International Conference on Healthcare Informatics (ICHI)
  76. Drugs, Money, and Secret Handshakes: The Unstoppable Growth of Prescription Drug Prices
    Robin Feldman · 2019
  77. Integrating Value Assessment Into Discussions About the Price of Cancer Drugs
    Craig A. Bunnell · 2012 · Mayo Clinic Proceedings
  78. Most Second-Generation Antipsychotic Prescriptions in Community Practice Are Neither FDA-Approved nor Within Prescribing Guideline Recommendations
    Sorabh Singhal, Casey Kloosterman, Joseph Billian, Teresa Bailey, Neelkamal S. Soares · 2021 · The Journal of Pediatric Pharmacology and Therapeutics
  79. Extremismo de direita estatal e governança médica: a experiência brasileira durante a pandemia de COVID-19
    Cláudio Lorenzo, Fabrício Monteiro Neves · 2024 · Revista crítica de ciências sociais/Revista crítica de ciências sociais
  80. Quality (Attributes) over quantity: Minimal essential quality attributes for determining antibody stability in postproduction handling stability studies
    Roderick van den Berg, Renske Penning, M. Reza Nejadnik, Wim Jiskoot, Tim Menzen, Enrico Mastrobattista · 2025 · Journal of Pharmaceutical Sciences
  81. Caution Is Warranted in Prescribing Ketamine for Mental Health
    Katherine Drabiak · 2025 · Journal of General Internal Medicine
  82. Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy
    Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt · 2026 · British Journal of Clinical Pharmacology
  83. Can Plant-Derived Anti-Inflammatory Compounds “Replace” Indomethacin in NSAID Therapy? Advances in Drug Delivery Systems of Indomethacin and Off-Label Medical Applications
    Petya Georgieva, Petya Peneva, Yana Gvozdeva · 2026 · Applied Biosciences
  84. After Amarin v FDA: What Will the Future Hold for Off-label Promotion Regulation?
    Tim Ken Mackey, Bryan A. Liang · 2016 · Mayo Clinic Proceedings
  85. The Applicability of N: Ancient Debates and Modern Experimental Design
    Katherine D. Van Schaik · 2018 · Healthcare
  86. “MAIS MAGRA, MAIS CALMA E MAIS INTELIGENTE”: A INTERNET COMO FACILITADORA DO USO OFF-LABEL DE MEDICAMENTOS
    Rosa, R., R. B. ALMEIDA · 2019 · Publicatio UEPG Ciencias Biologicas e da Saude
  87. „Off label use“ in der Palliativmedizin
    Constanze Rémi, Christina Gerlach · 2021 · Der Schmerz
  88. Off-Label Drug Use in Oncology
    Е. В. Карабина, Dina Sakaeva, Oleg Nikolaevich Lipatov · 2022 · Creative Surgery and Oncology
  89. Off-label drug use in an adult intensive care unit of a Brazilian hospital
    Elana Figueiredo Chaves, José Martins de Alcântara Neto, Lívia Maria Porto Moreira, Pedro Henrique Quintela Soares de Medeiros, Paulo Andrei Milen Firmino, Gabriela Araújo de Abreu, Angelina Almeida Bastos, Arnaldo Aires Peixoto, Marjorie Moreira Guedes · 2022 · Brazilian Journal of Pharmaceutical Sciences
  90. Pediatric Drug Development Process: A Review
    Chetan Sushir, Vaishali A. Kilor, Ashika Rewatkar · 2023 · Asian Journal of Pediatric Research
  91. Off-label medications for addictive disorders
    Tyler S. Vanderhoof · 2023 · Current Psychiatry
  92. Collaborative Approaches to Establishing and Implementing Pharmacovigilance Systems
    Brian David Edwards, Angela Caro-Rojas · 2024 · Springer eBooks
  93. Off-label drug use in palliative medicine: Delphi study for the consensus of evidence-based treatment recommendations
    Stefanie Pügge, Aleksandra Dukic-Ott, Julian Baumgärtel, Saskia Jünger, Claudia Bausewein, Constanze Rémi · 2025 · Palliative Medicine
  94. ASHP Guidelines on the Evaluation of Off-Label Medication Use in the Inpatient Setting
    Karin M Durant, Julie Gwin, Molly Billstein Leber, Nisha Mathew, Lisa Matonti, Margaret F Segovia, Cicely Williams · 2025 · American Journal of Health-System Pharmacy
  95. The Importance of Monitoring Patients’ Responses to Medications: Increased Arousal after Administration of Zolpidem in Those with Hypoxic Ischemic Encephalopathy—A Case Study
    Sylvia A. Duraski · 2015 · Rehabilitation Nursing
  96. Off‐label use of tumour necrosis factor‐alpha inhibitors and anakinra at an Australian tertiary hospital
    Matthew Linger, Mieke van Driel, Samantha Hollingworth, Jennifer H. Martin · 2016 · Internal Medicine Journal
  97. Precommitment Devices: A Defensible Treatment for Opioid Addiction?
    Rebecca Susan Dresser · 2020 · American Journal of Law & Medicine
  98. Using FDA-approved drugs as off-label fluorescent dyes for optical biopsies: from in silico design to ex vivo proof-of-concept
    Michael C Larson, Arthur F. Gmitro, Urs Utzinger, Andrew R. Rouse, Gregory J. Woodhead, Quinlan Carlson, Charles T. Hennemeyer, Jennifer K. Barton · 2021 · Methods and Applications in Fluorescence
  99. The Case for Real-World Data and Real-World Evidence Generation in Rare and Orphan Medicinal Drug Development
    Maryna Kolochavina · 2021 · Springer eBooks
  100. Off-Label Prescribing and Polypharmacy: Minimizing the Risks
    Laura G. Leahy · 2017 · Journal of Psychosocial Nursing and Mental Health Services